| Coupled degradation of a small regulatory RNA and its mRNA targets in Escherichia coli E Massé, FE Escorcia, S Gottesman Genes & development 17 (19), 2374-2383, 2003 | 872 | 2003 |
| Conscripts of the infinite armada: systemic cancer therapy using nanomaterials DA Scheinberg, CH Villa, FE Escorcia, MR McDevitt Nature reviews Clinical oncology 7 (5), 266-276, 2010 | 221 | 2010 |
| Nontranscriptional role of Hif-1α in activation of γ-secretase and notch signaling in breast cancer JC Villa, D Chiu, AH Brandes, FE Escorcia, CH Villa, WF Maguire, CJ Hu, ... Cell reports 8 (4), 1077-1092, 2014 | 142 | 2014 |
| Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery JJ Mulvey, CH Villa, MR McDevitt, FE Escorcia, E Casey, DA Scheinberg Nature nanotechnology 8 (10), 763-771, 2013 | 118 | 2013 |
| Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes CH Villa, MR McDevitt, FE Escorcia, DA Rey, M Bergkvist, CA Batt, ... Nano letters 8 (12), 4221-4228, 2008 | 99 | 2008 |
| Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors FE Escorcia, E Henke, MR McDevitt, CH Villa, P Smith-Jones, ... Cancer research 70 (22), 9277-9286, 2010 | 80 | 2010 |
| Immune checkpoint blockade in combination with stereotactic body radiotherapy in patients with metastatic pancreatic ductal adenocarcinoma C Xie, AG Duffy, G Brar, S Fioravanti, D Mabry-Hrones, M Walker, ... Clinical Cancer Research 26 (10), 2318-2326, 2020 | 71 | 2020 |
| Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand DS Abou, NA Thiele, NT Gutsche, A Villmer, H Zhang, JJ Woods, ... Chemical science 12 (10), 3733-3742, 2021 | 66 | 2021 |
| iNOS regulates the therapeutic response of pancreatic cancer cells to radiotherapy PMR Pereira, KJ Edwards, K Mandleywala, LM Carter, FE Escorcia, ... Cancer research 80 (8), 1681-1692, 2020 | 44 | 2020 |
| Targeted nanomaterials for radiotherapy FE Escorcia, MR McDevitt, CH Villa, DA Scheinberg Nanomedicine 2 (6), 805-815, 2007 | 43 | 2007 |
| Tumor response to radiopharmaceutical therapies: the knowns and the unknowns G Sgouros, YK Dewaraja, F Escorcia, SA Graves, TA Hope, A Iravani, ... Journal of Nuclear Medicine 62 (Supplement 3), 12S-22S, 2021 | 42 | 2021 |
| Radiotherapy and immune checkpoint blockade for melanoma: a promising combinatorial strategy in need of further investigation FE Escorcia, MA Postow, CA Barker The Cancer Journal 23 (1), 32-39, 2017 | 39 | 2017 |
| VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors F Röhrig, S Vorlová, H Hoffmann, M Wartenberg, FE Escorcia, S Keller, ... Oncogene 36 (1), 1-12, 2017 | 36 | 2017 |
| External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma NK Taunk, FY Moraes, FE Escorcia, LC Mendez, K Beal, GN Marta Expert review of anticancer therapy 16 (3), 347-358, 2016 | 32 | 2016 |
| Perspectives on metals-based radioimmunotherapy (RIT): moving forward JM White, FE Escorcia, NT Viola Theranostics 11 (13), 6293, 2021 | 30 | 2021 |
| Why bother with alpha particles? AP King, FI Lin, FE Escorcia European Journal of Nuclear Medicine and Molecular Imaging 49, 7-17, 2021 | 27 | 2021 |
| Tumor-specific Zr-89 immuno-PET imaging in a human bladder cancer model FE Escorcia, JM Steckler, D Abdel-Atti, EW Price, SD Carlin, WW Scholz, ... Molecular imaging and biology 20, 808-815, 2018 | 26 | 2018 |
| ImmunoPET predicts response to Met-targeted radioligand therapy in models of pancreatic cancer resistant to Met kinase inhibitors FE Escorcia, JL Houghton, D Abdel-Atti, PR Pereira, A Cho, NT Gutsche, ... Theranostics 10 (1), 151, 2020 | 25 | 2020 |
| Glypican-3-targeted alpha particle therapy for hepatocellular carcinoma MM Bell, NT Gutsche, AP King, KE Baidoo, OJ Kelada, PL Choyke, ... Molecules 26 (1), 4, 2020 | 23 | 2020 |
| H2BZmacropa-NCS: A Bifunctional Chelator for Actinium-225 Targeted Alpha Therapy KJ Kadassery, AP King, S Fayn, KE Baidoo, SN MacMillan, FE Escorcia, ... Bioconjugate chemistry 33 (6), 1222-1231, 2022 | 16 | 2022 |
Peter ChoykeMolecular Imaging Program, NCI在 nih.gov 的电子邮件经过验证
